KRBL Limited (KRBL) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
22 Oct, 2026Executive summary
Q3 FY25 revenue from operations reached a record Rs 1,682 crore, up 17% YoY, led by 104% export growth; domestic revenue declined 4%.
9M FY25 revenue rose 2% YoY to Rs 4,152 crore, while profitability margins narrowed amid higher input costs, freight and lower other income.
Auditors issued a qualified review conclusion regarding the ongoing ED investigation; except for its possible effects, nothing indicated material misstatement or disclosure non-compliance.
Financial highlights
Q3 total income was Rs 1,690 crore; EBITDA was Rs 203 crore and PAT Rs 133 crore.
9M FY25 EBITDA was Rs 482 crore and PAT Rs 322 crore; 9M PAT was Rs 32,184 lakh versus Rs 48,178 lakh a year earlier.
Q3 gross margin was 24.0%, EBITDA margin 12.0% and PAT margin 7.8%; 9M gross margin was 23.7%, EBITDA margin 11.6% and PAT margin 7.6%.
Q3 consolidated PBT was Rs 18,176 lakh versus Rs 17,864 lakh YoY; PAT was Rs 13,261 lakh versus Rs 13,384 lakh.
Consolidated EPS was Rs 5.79 for Q3 and Rs 14.06 for 9M, versus Rs 5.85 and Rs 20.68 YoY, respectively.
Outlook and guidance
Export plans emphasize channel deepening, market diversification, direct marketing, HORECA growth and economy variants in smaller packs.
Margins are expected to improve in FY26 as older, higher-cost inventory runs down and freight costs ease.
Saudi revenue is targeted to exceed Rs 500 crore by 2026; Uplife targets Rs 300 crore sales within three years, with positive product-level P&L expected by year two.
Strategic priorities include deeper domestic distribution, supply-chain changes, brand investment and entry into adjacent food categories; no quantified financial guidance was included.
Latest events from KRBL Limited
- Independent review launched after director’s resignation; export receivable write-off detailed.KRBL
Investor update - Q3 revenue rose 33% and PAT nearly tripled amid crop uncertainty and an ED-related qualified review.KRBL
Q3 22/23 - Record Q1 profit and domestic growth; unresolved ED investigation qualified the audit.KRBL
Q1 22/23 - Record Q2 results and surging exports, with higher procurement plans and unresolved ED matters.KRBL
Q2 22/23 - Record FY23 earnings, but Q4 margin pressure, ED uncertainty and negative operating cash flow persisted.KRBL
Q4 22/23 - Domestic growth offset export weakness as input costs pressured profits and the ED review remained qualified.KRBL
Q2 23/24 - Domestic growth was offset by export weakness, margin pressure and ED-related uncertainty.KRBL
Q3 23/24 - Q1 PAT rose sharply as exports surged, while ED proceedings remain an audit qualification.KRBL
Q1 25/26 - Record Q1 profitability despite export disruption; the ED matter qualified the review.KRBL
Q1 26/27